Mechanisms of chemoprotection by oltipraz
- 作者Thomas Kensier; Peter Stcyzynski; John Groopman; Kathy Helzlsouer; Thomas Curphey; Yulla Maxcultenko; B. D. Roebuck
- 卷第50卷
- 印刷ISSN0730-2312
- 电子ISSN1097-4644
- 文件大小624.57KB
- 发表时间1992
- DOI10.1002/jcb.240501331
- 页码167-172
Workgroup #2: Screening and detection reference range/clinical issues of PSACurtis J. Mettlin; Bruce Black; Fred Lee; Peter J. Littrup; André Dupont; Richard Babaian · 1993
Cost-effective prostate cancer detection. Reduction of low-yield biopsiesPeter J. Littrup; Robert A. Kane; Curtis J. Mettlin; Gerald P. Murphy; Fred Lee; Ants Toi; Robert Badalament; Richard Babaian · 1994
Characteristics of prostate cancers detected in a multimodality early detection programCurtis Mettlin; Gerald P. Murphy; Fred Lee; Peter J. Littrup; Arthur Chesley; Richard Babaian; Robert Badalament; Robert A. Kane; F. K. Mostofi · 1993
Optimizing the Protocol for Pulmonary Cryoablation: A Comparison of a Dual- and Triple-Freeze ProtocolJ. Louis Hinshaw; Peter J. Littrup; Nathan Durick; Winnie Leung; Fred T. Lee; Lisa Sampson; Christopher L. Brace · 2010
Transrectal ultrasound in the diagnosis and staging of local disease after I125 seed implantation for prostate cancerFred Lee; Soren Torp-Pedersen; Lawrence Meiselman; Douglas B. Siders; Peter Littrup; Richard P. Dorr; Francis J. Pauli · 1988
Percutaneous hepatic tissue ablation with radiofrequency or cold temperature monitored by CT in real time: Radiologic-pathologic correlationLee, Fred T.; Chosy, Susan G.; Warner, Thomas F.; Littrup, Peter J. · Academic Radiology · 1998
Predicted prostate specific antigen results using transrectal ultrasound gland volume. Differentiation of benign prostatic hyperplasia and prostate cancerFred Lee; Peter J. Littrup; Lise Loft-Christensen; Burnett S. Kelly Jr.; Timothy A. McHugh; Douglas B. Siders; Ann E. Mitchell; John E. Newby · 1992